<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of the evaluation of hepatomegaly in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of the evaluation of hepatomegaly in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of the evaluation of hepatomegaly in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael P Curry, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alan Bonder, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen M Robson, MD, MBA, FACG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 11, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H468980536"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The liver is an abdominal organ with multiple functions including filtering blood from the gastrointestinal (GI) tract, secreting bile into the GI tract, metabolizing drugs, and synthesizing proteins (eg, clotting factors). The liver's vascularity, location, and functions make it susceptible to several conditions that result in hepatomegaly, defined as enlargement of the liver beyond its normal size. Hepatomegaly may be suspected based on physical examination findings or imaging.</p><p>This topic provides an overview of normal liver size, causes of hepatomegaly, and an approach to evaluating hepatomegaly in adults. The diagnosis and management of hepatic injury in adults is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/15143.html" rel="external">"Management of hepatic trauma in adults"</a>.)</p><p>The approach to evaluating the adult patient with abnormal liver biochemical or function tests is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests"</a> and  <a class="medical medical_review" href="/z/d/html/3620.html" rel="external">"Diagnostic approach to the adult with jaundice or asymptomatic hyperbilirubinemia"</a>.)</p><p class="headingAnchor" id="H62206891"><span class="h1">PROPERTIES OF THE NORMAL LIVER</span></p><p class="headingAnchor" id="H18910210"><span class="h2">Size and location</span><span class="headingEndMark"> — </span>The liver is a wedge-shaped organ located in the right upper quadrant of the abdomen  (<a class="graphic graphic_figure graphicRef51176" href="/z/d/graphic/51176.html" rel="external">figure 1</a>). The liver typically extends from the fifth intercostal space to the right costal margin in the midclavicular line. By ultrasound, a normal liver span is usually &lt;16 cm in the midclavicular line; however, liver size varies with sex and body size [<a href="#rid1">1,2</a>]. For example, in a study including 2080 individuals, the median liver span (as measured by transabdominal ultrasound in the midclavicular line) for males was 14.5 cm and for females was 13.4 cm [<a href="#rid2">2</a>]. Liver span &gt;16 cm was found in 239 individuals (12 percent). </p><p>The normal liver weighs 1.4 to 1.5 kg in men and 1.2 to 1.4 kg in women [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H2461449142"><span class="h2">Consistency</span><span class="headingEndMark"> — </span>Normal liver consistency has been described as soft with a smooth contour, whereas a firm and/or nodular liver suggests underlying disease. </p><p class="headingAnchor" id="H18910224"><span class="h2">Anatomy</span><span class="headingEndMark"> — </span>Traditionally, the liver is divided into right and left lobes  (<a class="graphic graphic_figure graphicRef67698" href="/z/d/graphic/67698.html" rel="external">figure 2</a>). In the normal liver, the right lobe is larger than the left lobe and occupies the right hypochondrium. The smaller left lobe is flatter and is situated in the epigastrium and left hypochondrium. (See  <a class="medical medical_review" href="/z/d/html/15094.html" rel="external">"Overview of hepatic resection", section on 'Liver anatomy and physiology'</a>.)</p><p>The liver can be subdivided into eight segments based on vascular supply, each containing branches of the portal vein, hepatic artery, hepatic vein, and bile ducts  (<a class="graphic graphic_figure graphicRef81897" href="/z/d/graphic/81897.html" rel="external">figure 3</a>). There are no surface fissures or anatomic landmarks demarcating the individual segments. </p><p class="headingAnchor" id="H18910203"><span class="h2">Anatomic variations</span><span class="headingEndMark"> — </span>A nonenlarged liver may be palpable on physical examination or may be interpreted as hepatomegaly on imaging due to anatomic variations: </p><p class="bulletIndent1"><span class="glyph">●</span>Riedel's lobe – Riedel's lobe is a downward, tongue-like projection of the right lobe of the liver that extends below the level of the umbilicus and may give a false impression of hepatomegaly. The presence of Riedel's lobe can be confirmed on liver cross-sectional imaging (eg, computed tomography [CT], magnetic resonance imaging [MRI]), and it is regarded as a benign condition [<a href="#rid4">4,5</a>]. Riedel's lobe has been described as an accessory lobe of uncertain etiology with an incidence that varies from approximately 3 to 30 percent [<a href="#rid5">5</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Caudate lobe papillary process – Another anatomic variation that may be confused with hepatomegaly is projection of a papillary process from the caudate lobe (segment I)  (<a class="graphic graphic_figure graphicRef81897" href="/z/d/graphic/81897.html" rel="external">figure 3</a>). The caudate lobe papillary process may extend posteriorly, lying between the inferior vena cava (IVC) and aorta. Occasionally, the papillary process will wrap around the IVC such that its tip lies posterior to the IVC. This position of the papillary process may be mistakenly interpreted as hepatomegaly on imaging.</p><p></p><p class="headingAnchor" id="H468980572"><span class="h1">EXAMINING THE LIVER</span><span class="headingEndMark"> — </span>Hepatomegaly may be suspected based on physical examination or liver imaging. Liver percussion and palpation are common examination methods, while imaging is used frequently to assess liver size and texture, and to look for abnormalities such as focal lesions, or portal or hepatic vein thrombosis.</p><p class="headingAnchor" id="H62208039"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>Physical examination of the liver includes abdominal palpation and percussion [<a href="#rid6">6-9</a>]. To determine liver span, we percuss and palpate the liver in the midclavicular line with the patient in a supine position [<a href="#rid10">10</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Percussion – With the patient in a supine position and starting in the third intercostal space, the examiner uses percussion while moving inferiorly until dullness suggests the upper border of the liver (usually located in the fifth intercostal space). Next, percussion is performed from below the umbilicus in an area of tympany, and the examiner moves superiorly until dullness indicates the liver's inferior border.</p><p></p><p class="bulletIndent1">Percussion alone may underestimate liver size because the lower border of the liver may seem resonant to percussion. However, if the distance from the upper border of the liver to the percussed liver edge is &lt;13 cm, hepatomegaly is unlikely [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Palpation – The purpose of palpation is to estimate liver span and also check for tenderness or liver lesions. With the patient in a supine position, the examining hand is placed below the level of the dullness noted on percussion in the midclavicular line, parallel to the rectus muscle. The liver is palpated during deep inspiration as it moves inferiorly to meet the examiner's finger tips. The liver edge may be tender in patients with liver inflammation (eg, acute hepatitis) or congestion (eg, congestive heart failure). Alternatively, the liver edge may feel firm and nodular in patients with cirrhosis and/or malignancy. (See <a class="local">'Consistency'</a> above.)</p><p></p><p>Comparisons of estimating liver size by physical examination or ultrasound have been limited because the techniques typically use two different axes (ie, midclavicular line for physical examination and transaxial line for ultrasound) [<a href="#rid6">6,7,12</a>]. However, some data suggested that physical examination measurements correlated well with ultrasound examination. In a study of 101 adult patients with liver disease undergoing biopsy, the mean size measured by physical examination was 9 cm, while the mean size measured by ultrasound was 14 cm [<a href="#rid12">12</a>]. Using this data, an R factor of 0.70 was calculated, indicating strong correlation between measurement techniques.</p><p class="headingAnchor" id="H3479011769"><span class="h3">Palpable but nonenlarged liver</span><span class="headingEndMark"> — </span>In addition to anatomic variants, a normal, nonenlarged liver may be palpable because it is displaced below the right costal margin. Liver displacement may occur (see <a class="local">'Anatomic variations'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span>During deep inspiration</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with right pleural effusion</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with chronic obstructive pulmonary disease (hyperinflation of the chest with diaphragmatic descent may result in downward displacement of the liver)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with a thin body habitus</p><p></p><p class="headingAnchor" id="H468980579"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Imaging studies that are routinely used to assess the liver include:</p><p class="bulletIndent1"><span class="glyph">●</span>Ultrasound – Ultrasound is a common method to assess liver size and pathology, and transaxial ultrasound technique provides a quantitative measure of liver span [<a href="#rid6">6,12</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Computed tomography (CT) or magnetic resonance imaging (MRI) – Both CT and MRI can be used to determine liver size and volume [<a href="#rid13">13,14</a>]. Volumetric assessment traditionally has required manual contour tracing, segmentation of the organ in question, and application of mathematical algorithms to determine the volume. However, automated techniques have been developed that reduce the need for manual input, and thus the time needed to calculate volume [<a href="#rid15">15,16</a>]. Automated techniques appear to correlate well with manual contour tracing for volume determination [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1">CT is routinely used to measure total liver volume and segmental liver volume as part of the preoperative assessment for hepatic resection. Preoperative imaging prior to hepatic resection is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/15094.html" rel="external">"Overview of hepatic resection", section on 'Preoperative imaging'</a>.) </p><p></p><p class="headingAnchor" id="H62208353"><span class="h1">CAUSES</span></p><p class="headingAnchor" id="H3849883789"><span class="h2">Tender hepatomegaly</span></p><p class="headingAnchor" id="H62208375"><span class="h3">Acute hepatitis</span><span class="headingEndMark"> — </span>Hepatic inflammation is a nonspecific reaction to liver damage and may result in hepatomegaly. Causes of hepatic inflammation that are commonly associated with tender hepatomegaly include infection (eg, hepatitis A virus, hepatitis E virus, bacterial, parasitic), drug-induced liver injury, and alcoholic hepatitis [<a href="#rid17">17,18</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2692.html" rel="external">"Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3677.html" rel="external">"Hepatitis E virus infection"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2680.html" rel="external">"Pyogenic liver abscess", section on 'Clinical manifestations'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5676.html" rel="external">"Liver flukes: Fascioliasis", section on 'Clinical manifestations'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/3571.html" rel="external">"Drug-induced liver injury", section on 'Clinical manifestations'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/86934.html" rel="external">"Alcoholic hepatitis: Clinical manifestations and diagnosis", section on 'Clinical manifestations'</a>.)</p><p></p><p>For example, in a study of 59 patients with acute hepatitis A virus infection, 78 percent of patients had hepatomegaly at initial presentation [<a href="#rid18">18</a>]. </p><p class="headingAnchor" id="H1744750200"><span class="h3">Impaired venous outflow</span><span class="headingEndMark"> — </span>Hepatic congestion may develop if venous outflow from the liver is obstructed. Disorders leading to hepatic congestion that result in hepatomegaly and a firm, tender liver edge include: </p><p class="bulletIndent1"><span class="glyph">●</span>Budd-Chiari syndrome – Patients with acute Budd-Chiari syndrome (ie, hepatic venous outflow tract obstruction) typically present with right upper abdominal pain, ascites, and hepatomegaly. (See  <a class="medical medical_review" href="/z/d/html/3624.html" rel="external">"Etiology of the Budd-Chiari syndrome"</a>.)</p><p></p><p class="bulletIndent1">Budd-Chiari syndrome is categorized by disease severity and duration (eg, acute fulminant, acute nonfulminant, chronic) and is more common in women during the third or fourth decade of life. However, patients with chronic disease may be asymptomatic. With complete obstruction of the hepatic veins, caudate lobe compensatory hypertrophy may develop because venous drainage of the caudate lobe is frequently spared. (See  <a class="medical medical_review" href="/z/d/html/3562.html" rel="external">"Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Right heart failure – Patients with congestive hepatopathy and hepatomegaly from right-sided heart failure may present with dyspnea, fatigue, anorexia, chest discomfort, jaundice, jugular venous distension, and ascites. In patients with ascites, the diagnosis of right heart failure may be suggested by an elevated serum-to-ascites albumin gradient (SAAG; ≥1.1 g/dL) that can be distinguished from cirrhosis by a concomitantly elevated ascites total protein concentration (≥2.5 g/dL). (See  <a class="medical medical_review" href="/z/d/html/126513.html" rel="external">"Right heart failure: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1261.html" rel="external">"Evaluation of adults with ascites"</a>.)</p><p></p><p class="bulletIndent1">As an example, in patients with severe tricuspid regurgitation, the liver is often enlarged and tender, and may be pulsatile on palpation. (See  <a class="medical medical_review" href="/z/d/html/8119.html" rel="external">"Etiology, clinical features, and evaluation of tricuspid regurgitation"</a>.)</p><p></p><p class="bulletIndent1">In addition, patients with congestive hepatopathy frequently have mild elevations of serum total bilirubin (ie, bilirubin &lt;3 mg/dL), and the diagnosis and management of congestive hepatopathy is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3592.html" rel="external">"Congestive hepatopathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hepatic sinusoidal obstruction syndrome (SOS) – Hepatic SOS, previously termed veno-occlusive disease, is characterized by tender hepatomegaly, right upper quadrant pain, jaundice, and ascites, most often occurring in patients undergoing hematopoietic cell transplantation and less commonly following ingestion of alkaloid toxins (usually from herbal sources), high-dose radiation therapy to the liver, or liver transplantation. Regardless of the cause, SOS is thought to begin with injury to the hepatic venous endothelium. As sinusoidal pressure increases, sinusoidal dilatation, central congestion, and hepatomegaly develop. The pathogenesis, clinical manifestations, and diagnosis of hepatic SOS are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/129806.html" rel="external">"Hepatic sinusoidal obstruction syndrome (veno-occlusive disease) in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Peliosis hepatis – Peliosis hepatis is a rare vascular condition characterized by proliferation of the sinusoidal hepatic capillaries that results in cystic blood-filled cavities distributed randomly throughout the liver. Risk factors for peliosis hepatis include anabolic steroid use, immune deficiency, and some infections (eg, tuberculosis). Patients may present with jaundice, abdominal pain, hepatomegaly, and ascites. The pathogenesis, clinical features, and diagnosis of peliosis hepatis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3603.html" rel="external">"Peliosis hepatis"</a>.)</p><p></p><p class="headingAnchor" id="H193743191"><span class="h2">Nontender hepatomegaly</span></p><p class="headingAnchor" id="H3056498586"><span class="h3">Cholestatic liver disease</span><span class="headingEndMark"> — </span>Nontender hepatomegaly is a common clinical manifestation in patients with cholestatic liver disease such as primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC) [<a href="#rid19">19,20</a>]. Other common clinical features of PBC and PSC include fatigue and pruritus, although some patients are asymptomatic at presentation. The clinical features and diagnosis of PBC and PSC are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3621.html" rel="external">"Clinical manifestations, diagnosis, and prognosis of primary biliary cholangitis"</a> and  <a class="medical medical_review" href="/z/d/html/660.html" rel="external">"Primary sclerosing cholangitis in adults: Clinical manifestations and diagnosis"</a>.)</p><p>The diagnostic approach to adults with jaundice or asymptomatic hyperbilirubinemia is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3620.html" rel="external">"Diagnostic approach to the adult with jaundice or asymptomatic hyperbilirubinemia"</a>.)</p><p class="headingAnchor" id="H18910597"><span class="h3">Storage disorders</span><span class="headingEndMark"> — </span>Storage disorders that may result in hepatomegaly include:</p><p class="bulletIndent1"><span class="glyph">●</span>Disorders of lipid metabolism – Disorders of lipid metabolism can result in accumulation of toxic lipids, including triglycerides, within the liver: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Common disorders resulting in liver steatosis with nontender hepatomegaly include alcohol-associated fatty liver disease, nonalcoholic fatty liver disease, and diabetes mellitus. The accumulation of triglycerides results from excess delivery to and decreased export of free fatty acids from the liver. (See  <a class="medical medical_review" href="/z/d/html/3613.html" rel="external">"Pathogenesis of alcohol-associated liver disease"</a> and  <a class="medical medical_review" href="/z/d/html/3596.html" rel="external">"Pathogenesis of nonalcoholic fatty liver disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Lysosomal acid lipase deficiency is an uncommon disorder that may be associated with fatty liver and nontender hepatomegaly. Lysosomal acid lipase deficiency disease (also referred to as cholesteryl ester storage disease) is a milder phenotype of fulminant lysosomal acid lipase deficiency (Wolman disease) and presents with hepatomegaly and fatty liver in childhood or adulthood, depending on the lysosomal acid lipase activity [<a href="#rid21">21</a>]. This disorder is characterized by hepatic accumulation of cholesteryl esters and triglycerides, elevated serum aminotransferases, and dyslipidemia [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/115661.html" rel="external">"Metabolic dysfunction-associated steatotic liver disease in children and adolescents", section on 'Tests to exclude other liver diseases'</a> and  <a class="medical medical_review" href="/z/d/html/5813.html" rel="external">"Causes of primary adrenal insufficiency in children", section on 'Defects in cholesterol biochemistry'</a>.)</p><p></p><p class="bulletIndent2">The approach to the patient with hepatomegaly and a suspected inborn error of metabolism is presented separately. (See  <a class="medical medical_review" href="/z/d/html/2936.html" rel="external">"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features", section on 'Organomegaly'</a> and  <a class="medical medical_review" href="/z/d/html/17216.html" rel="external">"Inborn errors of metabolism: Identifying the specific disorder", section on 'Evaluation of specific presentations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Disorders of glycogen metabolism – Glycogen accumulation within hepatocytes may be seen in patients with poorly controlled diabetes mellitus and hepatomegaly [<a href="#rid23">23-25</a>]. For example, in a study of 36 patients with type 1 diabetes mellitus and glycogenic hepatopathy, 28 patients (78 percent) had hepatomegaly [<a href="#rid26">26</a>]. Glycogenic hepatopathy is distinct from steatohepatitis, and steatosis is usually absent on liver biopsy [<a href="#rid23">23</a>]. </p><p></p><p class="bulletIndent1">Several inborn errors of metabolism that result in glycogen storage disorders are commonly associated with hepatomegaly, including glucose-6-phosphatase deficiency (GSD I), glycogen debrancher deficiency (GSD III), liver phosphorylase deficiency (GSD IV), and liver phosphorylase kinase deficiency (GSD IXa1). These disorders are typically diagnosed in neonates, infants, and young children, and are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2941.html" rel="external">"Overview of inherited disorders of glucose and glycogen metabolism"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gaucher disease – Gaucher disease is a lysosomal disease that affects the recycling of cellular glycolipids, resulting in their accumulation within lysosomes of macrophages (eg, liver, spleen). Type 1 Gaucher disease has a variety of presenting features that may occur at any age, while liver enlargement is common and is typically two to three times normal size for age. Splenomegaly is also common. Patients may be asymptomatic or may present with early satiety, abdominal distension, and abdominal pain. The clinical manifestations and diagnosis of Gaucher disease are presented separately. (See  <a class="medical medical_review" href="/z/d/html/2918.html" rel="external">"Gaucher disease: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alpha-1 antitrypsin deficiency (AAT) – Liver disease in AAT deficiency is caused by pathologic polymerization of the variant AAT, resulting in intrahepatocyte accumulation of AAT molecules. Patients with liver manifestations of AAT deficiency may present with hepatomegaly, elevated aminotransferases, and ascites, and liver disease may progress to cirrhosis. Patients with AAT deficiency typically have respiratory symptoms (eg, dyspnea, cough). The clinical manifestation and diagnosis of AAT deficiency are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1464.html" rel="external">"Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/1429.html" rel="external">"Extrapulmonary manifestations of alpha-1 antitrypsin deficiency"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hereditary hemochromatosis – Hereditary hemochromatosis is an autosomal recessive disorder in which mutations in the <em>HFE</em> gene cause increased intestinal iron absorption. Progressive iron deposition in the liver is associated with hepatomegaly, elevated transaminases, and hepatic fibrosis that may progress to cirrhosis. However, with identification of the <em>HFE</em> gene, a laboratory diagnosis of hereditary hemochromatosis is often made in asymptomatic individuals before iron deposition results in symptoms such as lethargy, skin hyperpigmentation, diabetes mellitus, and arthralgias. (See  <a class="medical medical_review" href="/z/d/html/7167.html" rel="external">"Clinical manifestations and diagnosis of hereditary hemochromatosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Wilson disease – Liver is the initial site of copper accumulation in patients with Wilson disease, and hepatomegaly is among the clinical manifestations that also include abdominal pain and jaundice. (See  <a class="medical medical_review" href="/z/d/html/83837.html" rel="external">"Wilson disease: Clinical manifestations, diagnosis, and natural history"</a>.)</p><p></p><p class="headingAnchor" id="H62208389"><span class="h3">Infiltrative diseases</span><span class="headingEndMark"> — </span>Infiltrative disease that may result in hepatomegaly include:</p><p class="bulletIndent1"><span class="glyph">●</span>Granulomatous disease – Granulomas are found in the liver in several disorders, such as infection (eg, tuberculosis), autoimmune conditions (eg, sarcoidosis), and drug-induced liver injury [<a href="#rid27">27</a>]. Patients with granulomatous liver disease may have hepatomegaly in addition to fever, anorexia, or malaise, while symptoms may vary, depending on the underlying disease. The causes and evaluation of granulomatous liver disease is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3582.html" rel="external">"Evaluation of the adult patient with hepatic granuloma", section on 'Causes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hepatic amyloidosis – Hepatomegaly is common in patients with hepatic amyloidosis (primary or secondary). For example, in a study including 98 patients with hepatic amyloidosis, hepatomegaly was seen in over 80 percent of patients [<a href="#rid28">28</a>]. Associated signs and symptoms may include weight loss, abdominal pain, and elevated alkaline phosphatase. The clinical manifestations and diagnosis of hepatic amyloidosis are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2642.html" rel="external">"Gastrointestinal amyloidosis: Clinical manifestations, diagnosis, and management", section on 'Hepatic amyloidosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hepatosplenic T cell lymphoma – Hepatomegaly is a common clinical manifestation of hepatosplenic T cell lymphoma (HSTCL), a rare form of non-Hodgkin lymphoma. In addition to hepatomegaly, common signs and symptoms include splenomegaly, thrombocytopenia, pancytopenia, mildly abnormal aminotransferases and alkaline phosphatase. </p><p></p><p class="bulletIndent1">The liver is diffusely enlarged as liver sinusoids are markedly expanded by the lymphoma, and the clinical manifestations and diagnosis of HSTCL are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4714.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of hepatosplenic T cell lymphoma"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malignant tumors – Hepatomegaly may be seen in patients with hepatic infiltration by solid tumors. Common primary liver malignancies associated with nontender hepatomegaly include hepatocellular carcinoma and cholangiocarcinoma. In addition, patients with extensive liver metastases may also have hepatomegaly. (See  <a class="medical medical_review" href="/z/d/html/3597.html" rel="external">"Clinical features and diagnosis of hepatocellular carcinoma", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">"Clinical manifestations and diagnosis of cholangiocarcinoma", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Benign lesions – Benign liver lesions that may cause hepatomegaly include hepatic hemangiomas, hepatocellular adenomas, and focal nodular hyperplasia. These lesions typically appear as noncystic lesions on hepatic imaging: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/3594.html" rel="external">"Hepatic hemangioma"</a>.)</p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/3590.html" rel="external">"Hepatocellular adenoma"</a>.)</p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/3577.html" rel="external">"Focal nodular hyperplasia"</a>.)</p><p></p><p class="headingAnchor" id="H62208410"><span class="h3">Other conditions</span><span class="headingEndMark"> — </span>Hepatomegaly may be found in patients with cystic liver lesions:</p><p class="bulletIndent1"><span class="glyph">●</span>Caroli disease – Hepatomegaly is a common clinical manifestation of Caroli disease, a congenital disorder characterized by multifocal, segmental dilatation of large intrahepatic bile ducts. The condition is usually associated with renal cystic disease of varying severity. Patients with Caroli disease may develop abdominal pain, pruritus, bacterial cholangitis, ascites, and variceal bleeding. (See  <a class="medical medical_review" href="/z/d/html/650.html" rel="external">"Caroli disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Polycystic liver disease – Polycystic liver disease predominantly occurs in patients with autosomal dominant polycystic kidney disease (ADPKD), with an increasing burden of liver cysts occurring with age and in patients with more advanced renal disease. Women tend to develop cysts earlier in life, and massive cysts are more commonly seen in women. (See  <a class="medical medical_review" href="/z/d/html/1679.html" rel="external">"Autosomal dominant polycystic kidney disease (ADPKD): Extrarenal manifestations"</a>.)</p><p></p><p class="bulletIndent1">A less common disorder, autosomal dominant polycystic liver disease is distinct from ADPKD, since it is not associated with kidney involvement. Most patients with autosomal dominant polycystic liver disease are initially asymptomatic; however, with progressive enlargement and an increasing number of cysts, patients may present with abdominal distension, abdominal pain, nausea, and early satiety. (See  <a class="medical medical_review" href="/z/d/html/3588.html" rel="external">"Diagnosis and management of cystic lesions of the liver", section on 'Polycystic liver disease'</a>.) </p><p></p><p class="headingAnchor" id="H62208906"><span class="h1">INITIAL EVALUATION</span><span class="headingEndMark"> — </span>The initial evaluation of a patient with hepatomegaly includes obtaining a history to identify symptoms suggestive of underlying systemic disease and risk factors for liver disease, performing a physical examination to look for clues to the etiology and for signs of liver disease, and obtaining liver biochemical and function tests and Doppler ultrasound. Subsequent testing is determined based on the information gathered from the history and physical examination as well as the pattern of laboratory test abnormalities, if they are present. (See <a class="local">'Subsequent evaluation'</a> below.)</p><p class="headingAnchor" id="H1621183223"><span class="h2">History</span><span class="headingEndMark"> — </span>The initial evaluation includes obtaining a history to identify symptoms of systemic disease (eg, fever, weight loss) and risk factors for liver disease, including exposure to potential hepatotoxins (eg, alcohol, medications). While some patients with hepatomegaly are asymptomatic, other patients may report right upper quadrant pain or symptoms related to the underlying disorder. (See <a class="local">'Causes'</a> above.)</p><p class="headingAnchor" id="H2557963978"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>In addition to evaluating liver size and consistency, physical examination includes assessment for (see <a class="local">'Examining the liver'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span>Stigmata of chronic liver disease (eg, spider nevi, palmar erythema, gynecomastia) (see  <a class="medical medical_review" href="/z/d/html/1253.html" rel="external">"Cirrhosis in adults: Etiologies, clinical manifestations, and diagnosis", section on 'Physical examination'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased jugular venous pressure, a sign of right-sided heart failure (see <a class="local">'Impaired venous outflow'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Spleen size (a palpable spleen is two to threefold enlarged) (see  <a class="medical medical_review" href="/z/d/html/7134.html" rel="external">"Splenomegaly and other splenic disorders in adults", section on 'How to examine the spleen'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ascites (typically detected by flank dullness to percussion) (see  <a class="medical medical_review" href="/z/d/html/1261.html" rel="external">"Evaluation of adults with ascites", section on 'Physical examination'</a>)</p><p></p><p class="headingAnchor" id="H2234039053"><span class="h2">Diagnostic testing</span><span class="headingEndMark"> — </span>Initial laboratory testing is performed to look for abnormalities in liver biochemistries or function, while initial imaging evaluates liver size, consistency, and blood flow:</p><p class="bulletIndent1"><span class="glyph">●</span>Serum aminotransferases: alanine aminotransferase (ALT) and aspartate aminotransferase (AST)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alkaline phosphatase</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Total bilirubin</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Serum albumin</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prothrombin time/international normalized ratio</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Doppler ultrasound</p><p></p><p class="headingAnchor" id="H2857456513"><span class="h1">SUBSEQUENT EVALUATION</span><span class="headingEndMark"> — </span>Subsequent evaluation is based on results of the initial evaluation (laboratory tests and imaging in addition to signs and symptoms):</p><p class="headingAnchor" id="H1799022752"><span class="h2">Abnormal liver biochemical tests</span><span class="headingEndMark"> — </span>For patients with hepatomegaly and abnormal liver biochemical and/or function tests, additional diagnostic testing is performed based on the pattern of the laboratory findings, and the approach is discussed in detail separately:</p><p class="bulletIndent1"><span class="glyph">●</span>Hepatocellular (predominantly elevated transaminases) (see  <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Elevated serum aminotransferases'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cholestatic (predominantly elevated alkaline phosphatase) (see  <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Elevated alkaline phosphatase'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Isolated hyperbilirubinemia (see  <a class="medical medical_review" href="/z/d/html/3620.html" rel="external">"Diagnostic approach to the adult with jaundice or asymptomatic hyperbilirubinemia"</a>)</p><p></p><p class="headingAnchor" id="H2683928472"><span class="h2">Normal liver tests with imaging-confirmed hepatomegaly</span><span class="headingEndMark"> — </span>For patients with hepatomegaly but without liver biochemical or function test abnormalities, additional testing is typically based on signs or symptoms suggestive of systemic disease. As an example, for patients with fatigue, weight loss, hepatomegaly confirmed by ultrasound, and normal liver biochemical tests, subsequent evaluation includes serum and urine protein electrophoresis to evaluate for amyloidosis with hepatic involvement. (See  <a class="medical medical_review" href="/z/d/html/2642.html" rel="external">"Gastrointestinal amyloidosis: Clinical manifestations, diagnosis, and management"</a> and  <a class="medical medical_review" href="/z/d/html/6668.html" rel="external">"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis"</a>.)</p><p class="headingAnchor" id="H1374268540"><span class="h2">Normal liver tests and ultrasound</span><span class="headingEndMark"> — </span>For patients with hepatomegaly suspected by physical examination but without liver biochemical/function test or ultrasound abnormalities, additional testing is generally not required.</p><p class="headingAnchor" id="H1583882477"><span class="h2">Specialist referral</span><span class="headingEndMark"> — </span>Consultation with a hepatologist is obtained for patients with any of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute hepatitis with symptoms or signs of liver failure (eg, hepatic encephalopathy, coagulopathy) (see  <a class="medical medical_review" href="/z/d/html/3574.html" rel="external">"Acute liver failure in adults: Etiology, clinical manifestations, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Suspected chronic liver disease (eg, signs of portal hypertension such as ascites)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute or chronic liver disease requiring a specialized approach (eg, suspected Budd-Chiari syndrome)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms such as right upper quadrant or abdominal pain in the setting of hepatomegaly of uncertain etiology</p><p></p><p class="headingAnchor" id="H3730241421"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H232986082"><span class="h2">Pregnant women</span><span class="headingEndMark"> — </span>In late pregnancy, physical examination of the liver is difficult because of the expanding uterus. The liver is forced up further into the chest, and a palpable liver is an abnormal finding. In addition, spider angiomas and palmar erythema, which are associated with chronic liver disease, are common during pregnancy and usually disappear after delivery. The approach to liver disease occurring during pregnancy is presented separately. (See  <a class="medical medical_review" href="/z/d/html/3563.html" rel="external">"Approach to evaluating pregnant patients with elevated liver biochemical and function tests"</a>.)</p><p class="headingAnchor" id="H468980642"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Properties of the normal liver</strong> – The liver is a wedge-shaped organ located in the right upper quadrant of the abdomen  (<a class="graphic graphic_figure graphicRef51176" href="/z/d/graphic/51176.html" rel="external">figure 1</a>). The liver typically extends from the fifth intercostal space to the right costal margin in the midclavicular line. By ultrasound, a normal liver span is usually &lt;16 cm in the midclavicular line. (See <a class="local">'Properties of the normal liver'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Examining the liver</strong> – Hepatomegaly may be suspected based on physical examination or liver imaging. Liver percussion and palpation are common examination methods, while imaging is used frequently to assess liver size and texture, and to look for abnormalities such as focal lesions, or portal or hepatic vein thrombosis. (See <a class="local">'Examining the liver'</a> above.)</p><p></p><p class="bulletIndent1">For patients with hepatomegaly, ultrasound is a common method to assess liver size and pathology, and transaxial ultrasound technique provides a quantitative measure of liver span. (See <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes of hepatomegaly</strong> – Causes of tender hepatomegaly include acute hepatitis (eg, viral hepatitis, drug-induced liver disease) and disorders of impaired venous outflow (eg, Budd-Chiari syndrome, right-sided heart failure). (See <a class="local">'Tender hepatomegaly'</a> above.)</p><p></p><p class="bulletIndent1">Causes of nontender hepatomegaly include cholestatic liver diseases (eg, primary biliary cholangitis [PBC] or primary sclerosing cholangitis [PSC]), storage disorders (eg, lipids, glycogen), and infiltrative disorders (eg, hepatic amyloidosis). (See <a class="local">'Nontender hepatomegaly'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial evaluation</strong> – For patients with hepatomegaly, the initial evaluation includes obtaining a history to identify symptoms suggestive of underlying systemic disease and risk factors for liver disease, performing a physical examination to look for clues to the etiology and for signs of liver disease, and obtaining liver biochemical and function tests and Doppler ultrasound. (See <a class="local">'Initial evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subsequent evaluation</strong> – For patients with hepatomegaly and abnormal liver biochemical and/or function tests, additional diagnostic testing is performed based on the pattern of the laboratory findings, and the approach is discussed in detail separately (see <a class="local">'Abnormal liver biochemical tests'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hepatocellular (predominantly elevated aminotransferases) (see  <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Elevated serum aminotransferases'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cholestatic (predominantly elevated alkaline phosphatase) (see  <a class="medical medical_review" href="/z/d/html/3576.html" rel="external">"Approach to the patient with abnormal liver biochemical and function tests", section on 'Elevated alkaline phosphatase'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Isolated hyperbilirubinemia (see  <a class="medical medical_review" href="/z/d/html/3620.html" rel="external">"Diagnostic approach to the adult with jaundice or asymptomatic hyperbilirubinemia"</a>)</p><p></p><p class="bulletIndent1">Consultation with a hepatologist is obtained for patients with any of the following (see <a class="local">'Specialist referral'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute hepatitis with symptoms or signs of liver failure (eg, hepatic encephalopathy, coagulopathy) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Suspected chronic liver disease (eg, ascites)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Acute or chronic liver disease requiring a specialized approach (eg, suspected Budd-Chiari syndrome)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptoms such as right upper quadrant or abdominal pain in the setting of hepatomegaly of uncertain etiology</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Naylor CD. The rational clinical examination. Physical examination of the liver. JAMA 1994; 271:1859.</a></li><li><a class="nounderline abstract_t">Kratzer W, Fritz V, Mason RA, et al. Factors affecting liver size: a sonographic survey of 2080 subjects. J Ultrasound Med 2003; 22:1155.</a></li><li class="breakAll">Wolf DC. Evaluation of the size, shape, and consistency of the liver. In: Clinical methods: The history, physical, and laboratory examinations, 3rd edition, Walker HK, Hall WD, Hurst JW (Eds), Butterworths, Boston 1990.</li><li><a class="nounderline abstract_t">Sham R, Sain A, Silver L. Hypertrophic Riedel's lobe of the liver. Clin Nucl Med 1978; 3:79.</a></li><li><a class="nounderline abstract_t">Kudo M. Riedel's lobe of the liver and its clinical implication. Intern Med 2000; 39:87.</a></li><li><a class="nounderline abstract_t">Zoli M, Magalotti D, Grimaldi M, et al. Physical examination of the liver: is it still worth it? Am J Gastroenterol 1995; 90:1428.</a></li><li><a class="nounderline abstract_t">Joshi R, Singh A, Jajoo N, et al. Accuracy and reliability of palpation and percussion for detecting hepatomegaly: a rural hospital-based study. Indian J Gastroenterol 2004; 23:171.</a></li><li><a class="nounderline abstract_t">Gupta K, Dhawan A, Abel C, et al. A re-evaluation of the scratch test for locating the liver edge. BMC Gastroenterol 2013; 13:35.</a></li><li><a class="nounderline abstract_t">Reuben A. Examination of the abdomen. Clin Liver Dis (Hoboken) 2016; 7:143.</a></li><li class="breakAll">https://stanfordmedicine25.stanford.edu/the25/liver.html (Accessed on February 23, 2020).</li><li><a class="nounderline abstract_t">Castell DO, O'Brien KD, Muench H, Chalmers TC. Eastimation of liver size by percussion in normal individuals. Ann Intern Med 1969; 70:1183.</a></li><li><a class="nounderline abstract_t">Loloi J, Patel A, McDevitt P, et al. How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver Size Correlate? A Prospective Study. Am J Med 2019; 132:103.</a></li><li><a class="nounderline abstract_t">Karlo C, Reiner CS, Stolzmann P, et al. CT- and MRI-based volumetry of resected liver specimen: comparison to intraoperative volume and weight measurements and calculation of conversion factors. Eur J Radiol 2010; 75:e107.</a></li><li><a class="nounderline abstract_t">Kromrey ML, Ittermann T, vWahsen C, et al. Reference values of liver volume in Caucasian population and factors influencing liver size. Eur J Radiol 2018; 106:32.</a></li><li><a class="nounderline abstract_t">Farraher SW, Jara H, Chang KJ, et al. Liver and spleen volumetry with quantitative MR imaging and dual-space clustering segmentation. Radiology 2005; 237:322.</a></li><li><a class="nounderline abstract_t">Dello SA, van Dam RM, Slangen JJ, et al. Liver volumetry plug and play: do it yourself with ImageJ. World J Surg 2007; 31:2215.</a></li><li><a class="nounderline abstract_t">Chau TN, Lai ST, Tse C, et al. Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol 2006; 101:292.</a></li><li><a class="nounderline abstract_t">Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995; 171 Suppl 1:S15.</a></li><li><a class="nounderline abstract_t">Schiano TD, Bodian C, Schwartz ME, et al. Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. Transplantation 2000; 69:545.</a></li><li><a class="nounderline abstract_t">Long RG, Scheuer PJ, Sherlock S. Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology 1977; 72:1204.</a></li><li><a class="nounderline abstract_t">Zhang B, Porto AF. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr 2013; 56:682.</a></li><li><a class="nounderline abstract_t">Bernstein DL, Hülkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol 2013; 58:1230.</a></li><li><a class="nounderline abstract_t">Torbenson M, Chen YY, Brunt E, et al. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am J Surg Pathol 2006; 30:508.</a></li><li><a class="nounderline abstract_t">Asada S, Kawaratani H, Mashitani T, et al. Glycogenic Hepatopathy in Type 1 Diabetes Mellitus. Intern Med 2018; 57:1087.</a></li><li><a class="nounderline abstract_t">Kumar K, Mehershahi S, Chime C, et al. Glycogen Hepatopathy: A Rare and Underrecognized Cause of Recurrent Transaminitis in Patients with Uncontrolled Type 2 Diabetes Mellitus. Case Rep Gastroenterol 2018; 12:466.</a></li><li><a class="nounderline abstract_t">Mukewar S, Sharma A, Lackore KA, et al. Clinical, Biochemical, and Histopathology Features of Patients with Glycogenic Hepatopathy. Clin Gastroenterol Hepatol 2016.</a></li><li><a class="nounderline abstract_t">Moretti M, Lefesvre P, Jonckheer J. Cirrhosis and partial portal thrombosis leading to severe variceal bleeding, an unusual presentation of sarcoidosis. Acta Clin Belg 2022; 77:767.</a></li><li><a class="nounderline abstract_t">Park MA, Mueller PS, Kyle RA, et al. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 2003; 82:291.</a></li></ol></div><div id="topicVersionRevision">Topic 89223 Version 19.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8196144" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The rational clinical examination. Physical examination of the liver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14620885" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Factors affecting liver size: a sonographic survey of 2080 subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14620885" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Factors affecting liver size: a sonographic survey of 2080 subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/657671" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hypertrophic Riedel's lobe of the liver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10732821" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Riedel's lobe of the liver and its clinical implication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7661163" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Physical examination of the liver: is it still worth it?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15598999" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Accuracy and reliability of palpation and percussion for detecting hepatomegaly: a rural hospital-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23442829" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : A re-evaluation of the scratch test for locating the liver edge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31041050" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Examination of the abdomen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31041050" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Examination of the abdomen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5795743" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Eastimation of liver size by percussion in normal individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30243506" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver Size Correlate? A Prospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19782490" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : CT- and MRI-based volumetry of resected liver specimen: comparison to intraoperative volume and weight measurements and calculation of conversion factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30150048" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Reference values of liver volume in Caucasian population and factors influencing liver size.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16126927" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Liver and spleen volumetry with quantitative MR imaging and dual-space clustering segmentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17726630" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Liver volumetry plug and play: do it yourself with ImageJ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16454833" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7876641" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clinical manifestations of hepatitis A: recent experience in a community teaching hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10708109" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/870368" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Presentation and course of asymptomatic primary biliary cirrhosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23403440" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23485521" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16625098" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29279489" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Glycogenic Hepatopathy in Type 1 Diabetes Mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30283279" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Glycogen Hepatopathy: A Rare and Underrecognized Cause of Recurrent Transaminitis in Patients with Uncontrolled Type 2 Diabetes Mellitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28043933" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clinical, Biochemical, and Histopathology Features of Patients with Glycogenic Hepatopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34511045" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cirrhosis and partial portal thrombosis leading to severe variceal bleeding, an unusual presentation of sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530778" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
